Back to Markets
AGAgenus Inc

Agenus Inc

AGENNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$3.50

+0.1000 (+2.94%)

As of 05/29/26 EDT · USD

Compare
Low: $2.71Current: $3.50High: $7.34

Key Statistics

Open

$3.41

Day High

$3.50

Day Low

$3.30

Prev. Close

$3.40

VolumeShares traded today.

597.23K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$145.75M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

2.11

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$7.34

52W LowLowest price over the past 52 weeks.

$2.71

50D MAAverage closing price over the last 50 trading days.

$3.76

200D MAAverage closing price over the last 200 trading days.

$3.82

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+10.8%

1M

-8.9%

6M

-20.1%

YTD

+8.4%

1Y

+2.0%

About

Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.

agenusbio.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade AGEN

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.